Stent Placement for the Treatment of Gastroparesis

Olaya I. Brewer Gutierrez, Mouen Khashab

Research output: Contribution to journalReview article

Abstract

Gastroparesis is a syndrome of delayed gastric emptying. First-line treatment includes prokinetic medications. Those refractory to medical treatment are occasionally considered for endoscopic or surgical treatment options, with unpredictable response. The pylorus plays a key role in gastric emptying, with pylorospasm as the underlying mechanism of gastroparesis in some patients. Procedures aiming at disruption of the pylorus have improved gastroparesis symptoms in this subset of patients. These include transpyloric stenting, used for inpatients with refractory symptoms to allow hospital discharge or as a triage to assess symptoms response in patients considered for more definite therapies such as pyloromyotomy.

LanguageEnglish (US)
Pages107-115
Number of pages9
JournalGastrointestinal Endoscopy Clinics of North America
Volume29
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Gastroparesis
Stents
Gastric Emptying
Pylorus
Triage
Therapeutics
Inpatients

Keywords

  • Delayed gastric emptying
  • Gastroparesis
  • Pylorospasm
  • Transpyloric stenting

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Stent Placement for the Treatment of Gastroparesis. / Brewer Gutierrez, Olaya I.; Khashab, Mouen.

In: Gastrointestinal Endoscopy Clinics of North America, Vol. 29, No. 1, 01.01.2019, p. 107-115.

Research output: Contribution to journalReview article

@article{4049e5c0fdbc47ef93be984446a9b64c,
title = "Stent Placement for the Treatment of Gastroparesis",
abstract = "Gastroparesis is a syndrome of delayed gastric emptying. First-line treatment includes prokinetic medications. Those refractory to medical treatment are occasionally considered for endoscopic or surgical treatment options, with unpredictable response. The pylorus plays a key role in gastric emptying, with pylorospasm as the underlying mechanism of gastroparesis in some patients. Procedures aiming at disruption of the pylorus have improved gastroparesis symptoms in this subset of patients. These include transpyloric stenting, used for inpatients with refractory symptoms to allow hospital discharge or as a triage to assess symptoms response in patients considered for more definite therapies such as pyloromyotomy.",
keywords = "Delayed gastric emptying, Gastroparesis, Pylorospasm, Transpyloric stenting",
author = "{Brewer Gutierrez}, {Olaya I.} and Mouen Khashab",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.giec.2018.08.011",
language = "English (US)",
volume = "29",
pages = "107--115",
journal = "Gastrointestinal Endoscopy Clinics of North America",
issn = "1052-5157",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Stent Placement for the Treatment of Gastroparesis

AU - Brewer Gutierrez, Olaya I.

AU - Khashab, Mouen

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Gastroparesis is a syndrome of delayed gastric emptying. First-line treatment includes prokinetic medications. Those refractory to medical treatment are occasionally considered for endoscopic or surgical treatment options, with unpredictable response. The pylorus plays a key role in gastric emptying, with pylorospasm as the underlying mechanism of gastroparesis in some patients. Procedures aiming at disruption of the pylorus have improved gastroparesis symptoms in this subset of patients. These include transpyloric stenting, used for inpatients with refractory symptoms to allow hospital discharge or as a triage to assess symptoms response in patients considered for more definite therapies such as pyloromyotomy.

AB - Gastroparesis is a syndrome of delayed gastric emptying. First-line treatment includes prokinetic medications. Those refractory to medical treatment are occasionally considered for endoscopic or surgical treatment options, with unpredictable response. The pylorus plays a key role in gastric emptying, with pylorospasm as the underlying mechanism of gastroparesis in some patients. Procedures aiming at disruption of the pylorus have improved gastroparesis symptoms in this subset of patients. These include transpyloric stenting, used for inpatients with refractory symptoms to allow hospital discharge or as a triage to assess symptoms response in patients considered for more definite therapies such as pyloromyotomy.

KW - Delayed gastric emptying

KW - Gastroparesis

KW - Pylorospasm

KW - Transpyloric stenting

UR - http://www.scopus.com/inward/record.url?scp=85055873528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055873528&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2018.08.011

DO - 10.1016/j.giec.2018.08.011

M3 - Review article

VL - 29

SP - 107

EP - 115

JO - Gastrointestinal Endoscopy Clinics of North America

T2 - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

SN - 1052-5157

IS - 1

ER -